U2Bio Co Ltd
KOSDAQ:221800
U2Bio Co Ltd
U2Bio Co., Ltd. engages in the provision of in vitro diagnostics and medical information technology services. The company is headquartered in Seoul, Seoul and currently employs 96 full-time employees. The company went IPO on 2015-06-29. The firm is involved in the provision of the general diagnostic testing services, molecular diagnostic testing services, as well as medical information technology (IT) services. The general diagnostic testing services include the provision of diagnosis and inspection information such as immunological serology, hematology, urine and microbiology, and pathology excluding molecular diagnostics among in vitro diagnostic tests. The Molecular diagnostic testing services include the provision of diagnostic and testing information through tests such as urethritis, mastoiditis, vaginitis, and cervicitis. The medical IT services include the provision of customized medical services through software products.
U2Bio Co., Ltd. engages in the provision of in vitro diagnostics and medical information technology services. The company is headquartered in Seoul, Seoul and currently employs 96 full-time employees. The company went IPO on 2015-06-29. The firm is involved in the provision of the general diagnostic testing services, molecular diagnostic testing services, as well as medical information technology (IT) services. The general diagnostic testing services include the provision of diagnosis and inspection information such as immunological serology, hematology, urine and microbiology, and pathology excluding molecular diagnostics among in vitro diagnostic tests. The Molecular diagnostic testing services include the provision of diagnostic and testing information through tests such as urethritis, mastoiditis, vaginitis, and cervicitis. The medical IT services include the provision of customized medical services through software products.
